Lung cancer stage at diagnosis study
Part of Cancer, Lungs & breathing clinical trials.
This study looks at how the stage of lung cancer at diagnosis has changed over time using medical records. It does not test a new treatment but may help improve future care by understanding patterns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with lung cancer (by biopsy or cell sample).
- This is not a recurrence or relapse of a previous lung cancer.
- You have not had another cancer (other than non-melanoma skin cancer) diagnosed within the past 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how lung cancer screening practices relate to the types and stages of lung cancer patients develop. Researchers want to understand whether earlier detection through screening changes what kinds of lung cancer people get, which could help improve screening strategies in the future.
This study follows adults with confirmed lung cancer as they are diagnosed and treated in routine clinical practice. It aims to better understand how lung cancer is diagnosed and managed day-to-day, which may help improve future care.
This study builds a detailed lung-cancer database by collecting clinical and lab information from people newly diagnosed. It aims to help doctors better understand lung cancer and how patients are treated from the start.
This trial is looking at how well a lung cancer treatment improves survival. It enrolls adults with confirmed lung cancer who can safely take the study medicines and have cancer that can be measured on scans.
This observational study collects information from adults with lung cancer to better understand the disease over time. If you join, it helps researchers learn from real-world experiences rather than testing a new drug.
This study collects medical information and test results from people with lung cancer that has spread (or cannot be cured with local treatment). It does not test a new drug; it helps researchers better understand patients’ health and care needs over time.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.